The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens

This study has been completed.
Sponsor:
Collaborators:
Santa Clara Valley Health & Hospital System
University of California, Davis
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT00152061
First received: September 8, 2005
Last updated: June 18, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2005
  Estimated Primary Completion Date: No date given